Quarterly pharmacy formulary change notice

Similar documents
Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

AETNA BETTER HEALTH January 2017 Formulary Change(s)

HEALTH SHARE/PROVIDENCE (OHP)

AETNA BETTER HEALTH January 2017 Formulary Change(s)

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Step Therapy Criteria

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

2018 CareOregon Advantage Part D Formulary Changes

March 2018 P & T Updates

Health Partners Medicare Special 2018 Formulary Changes

Quarterly pharmacy formulary change notice

Aetna Better Health of Illinois Medicaid Formulary Updates

Quarterly Pharmacy Formulary Change Notice

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

San Francisco Health Plan (SFHP)

Health Partners Medicare Prime 2019 Formulary Changes

Emblem Medicaid 3Q18 Formulary Updates

Oregon Health Plan prescription benefit updates

Neighborhood Medicaid Formulary Changes: June 2017

2018 Step Therapy Criteria (List of Step Therapy Criteria)

HOW TO USE THE FORMULARY

Quarterly pharmacy formulary change notice

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Added, Removed or Changed. Added, Removed or Changed

San Francisco Health Plan (SFHP)

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

2018 Step Therapy (ST) Criteria

San Francisco Health Plan (SFHP)

Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

2017 Step Therapy (ST) Criteria

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

WellCare s South Carolina Preferred Drug List Update

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

2018 Medicare Part D Formulary Change

Quarterly pharmacy formulary change notice

2018 Step Therapy Criteria (List of Step Therapy Criteria)

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Quarterly Pharmacy Formulary Change Notice

Amerigroup Washington, Inc. to conduct postservice reviews of certain modifiers and services

Updates to your prescription benefits

Step Therapy Requirements. Effective: 11/01/2018

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

3 Tier Formulary Additions

Drugs That Require Step Therapy (ST) Step Therapy Medications

ANTICONVULSANT STEP THERAPY

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)

Provider update: Quarterly pharmacy formulary change notice

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Aspirin. Iron Supplements

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT MAY 29, 2012

Quarterly pharmacy formulary change notice

ATYPICAL ANTIPSYCHOTICS

Quarterly pharmacy formulary change notice

Step Therapy Requirements. Effective: 05/01/2018

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

GHC-SCW Mandated Coverage Alphabetical Index Last Updated 8/1/2018

Collaborative Practice Agreement

Date: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes

STEP THERAPY CRITERIA

Step Therapy Requirements

Updates to your prescription benefits

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

List 1 PRESCRIPTION DRUGS REQUIRING PRE-AUTHORIZATION LIBERTY HEALTH DRUG IDENTIFICATION NUMBER (DIN)

2018 Formulary Notice of Change Prescription Drug Plans

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

New Product to Market: Trelegy Ellipta Magellan Health, Inc. All rights reserved.

2018 Formulary Update

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes

LET S TALK PREVENTION

Transcription:

Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee meeting. Effective August 1, 2018, the changes outlined below apply to all members enrolled with Amerigroup Community Care. Effective for all patients on August 1, 2018 Therapeutic class Drug Revised status (EDIT ONLY) APIDRA 100 UNITS/ML VIAL APIDRA SOLOSTAR 100 UNITS/ML ADMELOG 100 UNIT/ML VIAL ADMELOG SOLOSTAR 100 UNIT/ML HUMULIN R 500 UNITS/ML VIAL HUMULIN R 500 UNITS/ML KWIKPEN EFFECTIVE FOR NEW STARTS ON 8/1/18; EFFECTIVE FOR ON 10/1/18 30MLS PER 30 DAYS ADDING PA TO PRODUCT Potential alternatives ADMELOG 100 UNIT/ML VIAL ADMELOG SOLOSTAR 100 UNIT/ML ANTIPERSPIRANTS HYPERCARE 15% SOLUTION DPP4s GLP1s GLP1s JENTADUETO 2.5 MG-1000 MG TAB JENTADUETO 2.5 MG-500 MG TAB JENTADUETO 2.5 MG-850 MG TAB JENTADUETO XR 2.5 MG-1,000 MG JENTADUETO XR 5 MG-1,000 MG TB TRADJENTA 5 MG TABLET TANZEUM 30 MG PEN INJECT TANZEUM 50 MG PEN INJECT OZEMPIC 0.25-0.5 MG DOSE PEN OZEMPIC 1 MG DOSE PEN WITH STEP THERAPY EFFECTIVE 4/1/18 JANUVIA JANUMET XR ST APPLIES OZEMPIC VICTOZA ST APPLIES HIV JULUCA 50-25 MG TABLET HIV HIV BIKTARVY SYMFI LO COVERED 1 TABLET DAILY https://providers.amerigroup.com NJPEC-1507-18 June 2018

ICS/LABA (AUTHORIZED GENERIC OF AIRDUO RESPICLICK) FLUTICASONE-SALMETEROL 55-14 FLUTICASONE-SALMETEROL 113-14 FLUTICASONE-SALMETEROL 232-14 ICS/LABA DULERA 100 MCG/5 MCG INHALER DULERA 200 MCG/5 MCG INHALER *AUTHORIZED GENERIC FOR AIRDUO RESPICLK FLUTICASONE- SALMETEROL BREO ELLITA IRON SUPPLEMENTS POLY-VI-SOL WITH IRON DROPS POLY-VI-SOL DROPS MISCELLANEOUS ANTINEOPLASTIC DRUGS MITOXANTRONE 20 MG/10 ML VIAL MITOXANTRONE 25 MG/12.5 ML VL MITOXANTRONE 30 MG/15 ML VIAL COVERED MISCELLANEOUS OPHTHALMOLOGICS VISUDYNE 15 MG VIAL COVERED NARCOTIC ANTAGONISTS NALOXONE 0.4 MG/ML CARPUJECT NALOXONE 2 MG/2 ML SYRINGE NALOXONE 0.4 MG/ML VIAL NALOXONE 4 MG/10 ML VIAL NARCAN NASAL SPRAY COPAY REMOVAL IMMUNOMODULATORS PROLEUKIN 22 MILLION UNIT VIAL ADD PA LAMA/LABA STIOLTO RESPIMAT INHAL SPRAY PHOSPHATE BINDERS PHOSPHATE BINDERS LANTHANUM CARB 500 MG TAB CHEW LANTHANUM CARB 750 MG TAB CHEW LANTHANUM CARB 1,000 MG TB CHW SEVELAMER 0.8 GM POWDER PACKET SEVELAMER 2.4 GM POWDER PACKET SEVELAMER CARBONATE 800 MG TAB VELPHORO 500 MG CHEWABLE TAB WITH PA ELIPHOS 667 MG TABLET CALCIUM ACETATE 667 MG LANTHANUM CHEW TAB SEVELAMER TAB/PACKET PRENATAL VITAMINS GENERIC OTC PRODUCTS ONLY PRENATAL VITAMINS BRAND OTC ALL RX PRODUCTS GENERIC OTC PRENATALS Page 2 of 5

SMOKING CESSATION AGENTS CHANTIX STARTING MONTH BOX CHANTIX 0.5 MG TABLET CHANTIX 1 MG CONT MONTH BOX CHANTIX 1 MG TABLET NICOTROL CARTRIDGE INHALER NICOTROL NS 10 MG/ML SPRAY EDITS WITH NO PA 07/01/18 No changes in preferred/nonpreferred status revision or addition to UM edit only. ANTICONVULSANTS ZONEGRAN 100 MG CAPSULE ANTIBIOTICS BAXDELA 450 MG TABLET 28 TABLETS PER FILL; 1 FILL PER 30 DAYS COUGH AND COLD COUGH AND COLD ANTIVIRALS ANTIVIRALS COUGH AND COLD PRODUCTS CONTAINING HYDROCODONE COUGH AND COLD PRODUCTS CONTAINING CODEINE PREVYMIS 240 MG/12 ML VIAL PREVYMIS 480 MG/24 ML VIAL PREVYMIS 240 MG TABLET PREVYMIS 480 MG TABLET MEMBERS EQUAL TO OR LESS THAN 18 REQUIRE PA MEMBERS EQUAL TO OR LESS THAN 18 REQUIRE PA 1 VIAL PER DAY 100 DAYS OF TREATMENT 100 DAYS OF TREATMENT ASTHMA XOPENEX 30 VIALS 90 VIALS PER 30 DAYS ATYPICAL ANTIPSYCHOTICS BILE ACIDS CONSTIPATION AGENTS ABILIFY MYCITE CHENODAL 250 MG TABLET ALUNBRIG 180 MG TABLET ALUNBRIG 90 MG-180 MG TAB PACK ALUNBRIG 90 MG TABLET SYMPROIC 0.2 MG TABLET BROVANA 15 MCG/2 ML SOLUTION PERFOROMIST 20 MCG/2 ML SOLN PA REQUIRED 7 TABLETS PER DAY 1 PACK IN 30 DAYS REVISED QL 2 TABLETS DAILY 2 VIALS (4ML) PER DAY 2 VIALS (4ML) PER DAY Page 3 of 5

GLP-1 RECEPTOR AGONIST GLP-1 RECEPTOR AGONIST HEPATITIS C TREATMENT AGENTS ICS ICS LIPID/CHOLESTEROL LOWERING AGENTS LONHALA MAGNAIR 25 MCG STARTER LONHALA MAGNAIR 25 MCG REFILL OZEMPIC 0.25-0.5 MG DOSE PEN OZEMPIC 1 MG DOSE PEN PEGINTRON 50 MCG KIT PEGASYS 180 MCG/0.5 ML SYRINGE PEGASYS 180 MCG/ML VIAL PEGASYS PROCLICK 180 MCG/0.5 PEGASYS PROCLICK 135 MCG/0.5 QVAR REDIHALER 40 MCG QVAR REDIHALER 80 MCG FLOLIPID NUEDEXTA 20-10 MG CAPSULE INGREZZA 40 MG CAPSULE INGREZZA 80 MG CAPSULE NEUROPATHIC PAIN LYRICA 82.5 NEUROPATHIC PAIN LYRICA 165 NEUROPATHIC PAIN LYRICA 330 PANCREATIC ENZYMES PANCREATIC ENZYMES POTASSIUM SPARING DIURETICS PROGESTINS PSYCHOTHERAPEUTIC AGENTS PULMONARY ARTERIAL HYPERTENSION SGLT2 PERTZYE DR 24,000 UNIT CAPSULE VIOKASE CAROSPIR 25 MG/5 ML SUSPENSION CRINONE 4% GEL CRINONE 8% GEL ADZENYS ER 1.25 MG/ML SUSP TRACLEER 32 MG TABLET FOR SUSP XIGDUO XR 2.5 MG-1,000 MG TAB 1 KIT PER 30 DAYS 1 PER 30 DAYS 1 PEN PER 28 DAYS 2 PENS PER 28 DAYS REMOVE PA 1 INHALER PER 30 DAYS 2 INHALERS PER 30 DAYS 5MLS PER DAY 2 CAPSULES PER DAY REVISED QL 25 CAPSULES PER DAY 25 TABLETS PER DAY ADD PA AND QL 20ML PER DAY 1 APPLICATORFUL PER DAY 15ML PER DAY 32 MG TABS FOR SUSP 4 TABLETS PER DAY 2 TABLETS PER DAY Page 4 of 5

SGLT2 SGLT2 SGLT2/DPP-4 INHIBITOR SUBSTANCE USE DISORDERS STEGLATRO 5 MG TABLET STEGLATRO 15 MG TABLET SEGLUROMET 7.5-1,000 MG TABLET SEGLUROMET 2.5-500 MG TABLET SEGLUROMET 7.5-500 MG TABLET SEGLUROMET 2.5-1,000 MG TABLET STEGLUJAN 5-100 MG TABLET STEGLUJAN 15-100 MG TABLET SUBLOCADE 300 MG/1.5 ML SYRING SUBLOCADE 100 MG/0.5 ML SYRING LOPROX 0.77% CREAM LOTRIMIN ULTRA 1% CREAM NYSTATIN 100,000 UNIT/GM CREAM NYSTATIN 100,000 UNITS/GM OINT KETOCONAZOLE 2% CREAM OXISTAT 1% CREAM 2 TABLETS PER DAY 1 SYRINGE EVERY 28 DAYS 90 GMS PER 30 DAYS 30 GMS PER 30 DAYS 120 GMS PER 30 DAYS 60 GMS PER 30 DAYS What action do I need to take? Please review these changes and work with your patients to transition them to formulary alternatives. If you determine preferred formulary alternatives are not clinically appropriate for specific patients, you will need to obtain prior authorization (PA) to continue coverage beyond the applicable effective date. What if I need assistance? We recognize the unique aspects of patients cases. If for medical reasons your patient cannot be converted to a formulary alternative, call our Pharmacy department at 1-800-454-3730 and follow the voice prompts for pharmacy PA. You can find the Preferred Drug List on our provider website at https://providers.amerigroup.com/nj. If you need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-800-454-3730. Page 5 of 5